Viewing Study NCT00792506


Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2026-03-26 @ 5:58 AM
Study NCT ID: NCT00792506
Status: TERMINATED
Last Update Posted: 2022-02-02
First Post: 2008-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: Italfarmaco
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module